Successful use of diltiazem in calcinosis caused by connective tissue disease

Journal of Clinical Rheumatology

Volumn 5, Issue 2, 1999, Pages 74-78

  Torralba, Tito P ^a   Li Yu, Julie ^a   Navarra, Sandra T G V ^a  

^a UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

Author keywords

Calcinosis; Diltiazem

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM;

ADULT; ARTICLE; CALCINOSIS; CASE REPORT; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DOSE RESPONSE; EDEMA; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN TISSUE; MUSCLE WEAKNESS; PRIORITY JOURNAL; RASH; TACHYCARDIA;

EID: 0032912696     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199904000-00007     Document Type: Article

References (37)

1. Cohen MG, Nash P, Webb J. Calcification is rare in adult-onset dermatopolymyositis. Clin Rheumatol 1986;5:512-6.
2. Bowyer SL, Blane CE, Sullivan DB, Cassidy JT. Childhood dermatomyositis. Factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983;103: 882-8.
3. Rider LG, Okada S, Sherry DD, Wallace CA, Zemel LS, Jacobs JC, et al. Epidemiologie features and environmental exposures associated with illness onset in juvenile idiopathic inflammatory myopathy. Arthritis Rheum 1995; 38 Suppl:362.
4. Miller JJ. Late progression in dermatomyositis in childhood. J Pediatr 1973;83:543-8.
5. Berger RG, Featherstone GL, Rassh RH, McCartney WH, Hadler NM. Treatment of calcinosis universalis with low-dose warfarin. Am J Med 1987;83.-72-6.
6. Berger RG, Hadler NM. Treatment of calcinosis universalis secondary to dermatomyositis or scleroderma with low-dose warfarin. Arthritis Rheum 1983;26:511.
7. Lian JB, Pachman LM, Gundberg CM, Partridge RE, Maryjowski MC. Gamma-carboxyglutamate excretion and calcinosis in juvenile dermatomyositis. Arthritis Rheum 1982;25:1094-100.
8. Moore SE, Jump AA, Smiley DD. Effect of warfarin sodium on excretion of 4-carboxyglutamic acid in scleroderma, dermatomyositis and myositis ossificans progressiva. Arthritis Rheum 1986;29:344-51.
9. Fuchs D, Fructer L, Fishel B, Holtzman M, Yaron M. Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol 1986;5:527-30.
10. Taborn J, Bole GG, Thompson GR. Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis. Ann Intern Med 1978;89: 648-9.
11. Pachman LM. Juvenile dermatomyositis. Pediatr Rheum Clin North Am 1986;33:1097-1117.
12. Lee SS, Felsentein J, Tanzer FR. Calcinosis cutis circumscripta: Treatment with an intralesional corticosteroid. Arch Dermatol 1978;114: 1080-1.
13. Cram RL, Barmada R, Geno WB, Ray RD. Diphosphonate treatment of calcinosis universalis. N Engl J Med 1971;285:1012-3.
14. Metzger AL, Singer FR, Bluestone R, Pearson CM. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. N Engl J Med 1974;291:1294-6.
15. Berggren RB, Long PM, Trevaskis AE, Ranmdall P. Calcinosis circumscripta: Report of a case involving the hands. Plast Reconstr Surg 1965;36:609-88.
16. Sclenker JD, Clark DD, Weckesser EC. Calcinosis circumscripta of the hand in scleroderma. J Bone Joint Surg 1973;55:1051-6.
17. Mendelson BC, Linschelid RL, Dobyns JH, Muller SA. Surgical treatment of calcinosis cutis in the upper extremity. J Hand Surg 1977; 2:318-24.
18. Jones NF, Imbriglia JE, Steen VD, Medsger TA. Surgery for scleroderma of the hand. J Hand Surg 1987;12A:391.
19. Cousins MAM, Jones DB, Whyte MP, Monafo WW. Surgical management of calcinosis cutis universalis in systemic lupus erythematosus. Arthritis Rheum 1997;40:570-2.
20. Bodermer C, Teillac D, Le Bourgeois M, Wechsler B, de Prost Y. Efficacy of intravenous immunoglobulin in sclerodermatomyositis. Br J Dermatol 1990;123:545-6.
21. Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM. Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 1991;91:169-72.
22. Vedanarayanan V, Subramony SH, Ray LI, Evans OB. Treatment of childhood dermatomyositis with high dose of intravenous immunoglobulin. Pediatr Neural 1995;13:336-9.
23. Rasmussen H, Palmieri GMA. Altered cell calcium metabolism and human disease. In: Rubin RP, Weiss GB, Putney JW, editors. Calcium in biological systems. New York: Plenum Press; 1985.
24. Blaustein MP. The interrelationship between sodium and calcium fluxes across cell membranes. Rev Physiol Biochem Pharmacol 1974; 70:34-82.
25. Bertorini TE, Bhattacharya SK, Palmieri GMA, Chesney CM, Pifer D, Baker B. Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 1982;32:1088-92.
26. Ebashi S, Sugita M. The role of calcium in physiological and pathological processes of skeletal muscles. Aguayo AJ, Kourpati G, editors. In: Current topics in nerve and muscle research. Amsterdam: Excerpta Medica, 1979.
27. Johnson PL, Bhattacharya SK. Regulation of membrane-mediated chronic muscle degeneration in dystrophic hamsters by calciumchannel blockers: diltiazem, nifedipine, and verapamil. J Neurol Sci 1993;115:76-90.
28. Schwartz A. Molecular studies of the calcium channel antagonist binding site on calcium channels. Am J Cardiol 1994;73:12B-14B.
29. Palmieri GM, Sebes JL, Aelion JA. Treatment of calcinosis with diltiazem. Arthritis Rheum 1995;38:1646-54.
30. Bhattacharya SL, Palmieri GMA, Bertorini TE, Nutting DF. The effects of diltiazem in dystrophic hamsters. Muscle Nerve 1982;5:73-8.
31. Dieppe P. Crystal deposition disease and the soft tissues. Clin Rheum Dis 1979;5:807-22.
32. Vasudevan S, Zimmermann B, Lally EV. Treatment-resistant diffuse calcinosis in scleroderma. J Clin Rheumatol 1996;2:227-9.
33. Farah MJ, Palmieri GMA, Sebes JL, Cremer MA, Massie JD, Pinals RS. The effect of diltiazem on calcinosis in a patient with the CREST syndrome. Arthritis Rheum 1990;33: 1287-93.
34. Palmieri GM, Sebes JL, Aelion JA. Treatment of calcinosis with diltiazem. Arthritis Rheum 1995;38:1646-54.
35. Dolan AL, Kassimos D, Gibson T, Kingsley GH. Diltiazem induces remission of calcinosis in scleroderma. Br J Rheumatol 1995;34: 576-8.
36. Oddis CV. Therapy of inflammatory myopathy. Rheum Dis Clin North Am 1994;20:899-918.
37. Olivieri MG, Palermo R, Mautaleon C, Hübscher O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 1996;23:2151-5.